Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-penetreotide in carcinoid tumours

European Journal of Cancer Part A

Volumn 32, Issue 11, 1996, Pages 1924-1932

  Taal, B G ^a,b   Hoefnagel, C A ^a   Valdes Olmos R A ^a   Boot, Henk ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

131I MIBG; Carcinoid; Radionuclide imaging; Somatostatin

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; PENTETREOTIDE; PENTETREOTIDE IN 111; POTASSIUM IODIDE;

ADULT; AGED; ARTICLE; CARCINOID; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCINTISCANNING;

EID: 0005825116     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00241-9     Document Type: Article

References (13)

1. 1. Norton JA, Levin B, Jensen KT. Carcinoid tumours. In DeVita VT, Hellman S, Rosenberg SA, eds. Principles and Practice in Oncology, 4th edn. JB Lippincott, Philadelphia, 1993, 1371-1386.
2. 131I-metaiodobenzylguanidine. Lancet 1994, 2, 165 (letter).
3. 3. Hoemagel CA, den Hartog Jager FCA, van Gennip AH, Marcuse HR, Taal BG. Diagnosis and treatment of a carcinoid tumor using iodine-131 metaiodobenzylguanidine. Clin Nucl Med 1986, 11, 150-152.
4. 4. Feldman JM, Blinder RA, Lucas KJ, Coleman RE. Iodine 131 metaiodobenzylguanidine scintigraphy of carcinoid tumors. J Nucl Med 1986, 27, 1691-1696.
5. 131I-MIBG in the imaging of metastatic carcinoid tumours. Br J Cancer 1988, 58, 663-664.
6. 131I-metaiodobenzylguanidine therapy in carcinoids. J Nucl Biol Med 1991, 35, 346-348.
7. 7. Hoefnagel CA. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med 1994, 21, 561-581.
8. 8. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PM, Lamberts SWJ. Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 1993, 20, 283-292.
9. 9. Krenning EP, Bakker WH, Kooij PPM, et al. Somatostatin receptor scintigraphy with Indium-111-DPTA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med 1992, 33, 652-658.
10. 10. Bomanji J, Ur E, Mather S, et al. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors. J Nucl Med 1992, 33, 1121-1124.
11. 11. Hoemagel CA, den Hartog Jager FCA, Taal BG, Abeling NGGM, Engelsman E. The role of I-131-MIBG in the diagnosis and therapy of carcinoids. Eur J Nucl Med 1987, 13, 187-191.
12. 12. Dörr U, Rath U, Sautter-Bihl ML, et al. Improved visualisation of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue. Eur J Nucl Med 1993, 20, 431-433.
13. 13. Taal BG, Hoefnagel CA, Valdés Olmos RA, Boot H, Beijnen JH. Palliative effect of meta-iodobenzylguanidine in metastatic carcinoid tumours. J Clin Oncol 1996, 14, 1829-1838.